HHS directed NIAID to terminate Consortia for HIV/AIDS Vaccine Development funding, ending $258M federal HIV vaccine program
On May 30, 2025, NIAID verbally notified researchers at Scripps Research and Duke University that the Trump administration was terminating the Consortia for HIV/AIDS Vaccine Development (CHAVD), a $258 million, seven-year NIH-funded program representing the largest single federal investment in HIV vaccine research. NIAID also ended funding for three monkey-model vaccine research groups. The termination came as CHAVD researchers were preparing to begin clinical trials on a broadly neutralizing antibody approach that scientists described as the most promising HIV vaccine lead in decades. An HHS spokesperson cited "complex and duplicative health programs" as justification.
